Pankaj Mohan
Chairman, President and CEO, Director · Sonnet BioTherapeutics Holdings, Inc.
Individual
- 2024
- Dec 5, 2024
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Pankaj Mohan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
- Framework Ventures IV L.P. - $42.62M in SDEV purchases and sales in the last 12 months
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
- Jesse J. Geiger - $41.11M in MEDP purchases and sales in the last 12 months
- Mark Hancock - $40.97M in PACS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Pankaj Mohan?
Pankaj Mohan is a corporate insider, tracked as Chairman, President and CEO, Director of Sonnet BioTherapeutics Holdings, Inc. (SONN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Pankaj Mohan last file a Form 4?
The only primary Form 4 on record is dated 5 December 2024.
